Perform Another (Advanced) Search

1.  Study Posting (5031) Trial #155066, Kidney Cancer, Various Cities, WA
...Study Posting (5031) Trial #155066, Kidney Cancer, Various Cities, WA Trial Information Kidney Cancer Disease Study CRAD001L2201 Novartis is conducting this clinical research study to determine the effects ...
View Page

2.  Study Posting (5031) Trial #139146, Kidney Cancer, Various Cities, TX
...Study Posting (5031) Trial #139146, Kidney Cancer, Various Cities, TX Trial Information Kidney Cancer Disease Study CRAD001L2201 Novartis is conducting this clinical research study to determine the effects ...
View Page

3.  Study Posting (5031) Trial #139144, Kidney Cancer, Various Cities, PA
...Study Posting (5031) Trial #139144, Kidney Cancer, Various Cities, PA Trial Information Kidney Cancer Disease Study CRAD001L2201 Novartis is conducting this clinical research study to determine the effects ...
View Page

4.  Study Posting (5031) Trial #139142, Kidney Cancer, Various Cities, NV
...Study Posting (5031) Trial #139142, Kidney Cancer, Various Cities, NV Trial Information Kidney Cancer Disease Study CRAD001L2201 Novartis is conducting this clinical research study to determine the effects ...
View Page

5.  Study Posting (5031) Trial #139141, Kidney Cancer, Various Cities, MI
...Study Posting (5031) Trial #139141, Kidney Cancer, Various Cities, MI Trial Information Kidney Cancer Disease Study CRAD001L2201 Novartis is conducting this clinical research study to determine the effects ...
View Page

6.  Study Posting (5031) Trial #139140, Kidney Cancer, Various Cities, CA
...Study Posting (5031) Trial #139140, Kidney Cancer, Various Cities, CA Trial Information Kidney Cancer Disease Study CRAD001L2201 Novartis is conducting this clinical research study to determine the effects ...
View Page

7.  Study Posting (5031) Trial #139139, Kidney Cancer, Various Cities, AR
...Study Posting (5031) Trial #139139, Kidney Cancer, Various Cities, AR Trial Information Kidney Cancer Disease Study CRAD001L2201 Novartis is conducting this clinical research study to determine the effects ...
View Page

8.  Study Posting (4519) Trial #124254, Kidney Transplantation, Malmoe, Sweden
...Study Posting (4519) Trial #124254, Kidney Transplantation, Malmoe, Sweden Trial Information A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant Patients Status: Completed Protocol Number: M67005 Sponsor: Hoffmann-La Roche Company ...
View Page

9.  Study Posting (4519) Trial #125691, Kidney Transplantation, Goeteborg, Sweden
...Study Posting (4519) Trial #125691, Kidney Transplantation, Goeteborg, Sweden Trial Information A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant Patients Status: Completed Protocol Number: M67005 Sponsor: Hoffmann-La Roche Company ...
View Page

10.  Study Posting (4519) Trial #123188, Kidney Transplantation, Valencia, Spain
...Study Posting (4519) Trial #123188, Kidney Transplantation, Valencia, Spain Trial Information A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant Patients Status: Completed Protocol Number: M67005 Sponsor: Hoffmann-La Roche Company ...
View Page

11.  Study Posting (4519) Trial #123183, Kidney Transplantation, Santander, Spain
...Study Posting (4519) Trial #123183, Kidney Transplantation, Santander, Spain Trial Information A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant Patients Status: Completed Protocol Number: M67005 Sponsor: Hoffmann-La Roche Company ...
View Page

12.  Study Posting (4519) Trial #123171, Kidney Transplantation, Malaga, Spain
...Study Posting (4519) Trial #123171, Kidney Transplantation, Malaga, Spain Trial Information A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant Patients Status: Completed Protocol Number: M67005 Sponsor: Hoffmann-La Roche Company ...
View Page

13.  Study Posting (4519) Trial #126152, Kidney Transplantation, Córdoba, Spain
...Study Posting (4519) Trial #126152, Kidney Transplantation, Córdoba, Spain Trial Information A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant Patients Status: Completed Protocol Number: M67005 Sponsor: Hoffmann-La Roche Company ...
View Page

14.  Study Posting (4519) Trial #122634, Kidney Transplantation, Barcelona, Spain
...Study Posting (4519) Trial #122634, Kidney Transplantation, Barcelona, Spain Trial Information A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant Patients Status: Completed Protocol Number: M67005 Sponsor: Hoffmann-La Roche Company ...
View Page

15.  Study Posting (4519) Trial #124247, Kidney Transplantation, Wroclaw, Poland
...Study Posting (4519) Trial #124247, Kidney Transplantation, Wroclaw, Poland Trial Information A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant Patients Status: Completed Protocol Number: M67005 Sponsor: Hoffmann-La Roche Company ...
View Page

16.  Study Posting (4519) Trial #125649, Kidney Transplantation, Warszawa, Poland
...Study Posting (4519) Trial #125649, Kidney Transplantation, Warszawa, Poland Trial Information A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant Patients Status: Completed Protocol Number: M67005 Sponsor: Hoffmann-La Roche Company ...
View Page

17.  Study Posting (4519) Trial #122589, Kidney Transplantation, Oslo, Norway
...Study Posting (4519) Trial #122589, Kidney Transplantation, Oslo, Norway Trial Information A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant Patients Status: Completed Protocol Number: M67005 Sponsor: Hoffmann-La Roche Company ...
View Page

18.  Study Posting (4519) Trial #123853, Kidney Transplantation, Monterrey, Mexico
...Study Posting (4519) Trial #123853, Kidney Transplantation, Monterrey, Mexico Trial Information A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant Patients Status: Completed Protocol Number: M67005 Sponsor: Hoffmann-La Roche Company ...
View Page

19.  Study Posting (4519) Trial #123091, Kidney Transplantation, Muenster, Germany
...Study Posting (4519) Trial #123091, Kidney Transplantation, Muenster, Germany Trial Information A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant Patients Status: Completed Protocol Number: M67005 Sponsor: Hoffmann-La Roche Company ...
View Page

20.  Study Posting (4519) Trial #122507, Kidney Transplantation, Hannover, Germany
...Study Posting (4519) Trial #122507, Kidney Transplantation, Hannover, Germany Trial Information A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant Patients Status: Completed Protocol Number: M67005 Sponsor: Hoffmann-La Roche Company ...
View Page